You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

EXTENDED PHENYTOIN SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Extended Phenytoin Sodium, and what generic alternatives are available?

Extended Phenytoin Sodium is a drug marketed by Amneal Pharms Ny, Ani Pharms, Lupin Ltd, Mylan, Sun Pharm Inds, Sun Pharm Inds (in), Taro, Unichem, Wockhardt, and Wockhardt Usa. and is included in eleven NDAs.

The generic ingredient in EXTENDED PHENYTOIN SODIUM is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Extended Phenytoin Sodium

A generic version of EXTENDED PHENYTOIN SODIUM was approved as phenytoin sodium by WEST-WARD PHARMS INT on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EXTENDED PHENYTOIN SODIUM?
  • What are the global sales for EXTENDED PHENYTOIN SODIUM?
  • What is Average Wholesale Price for EXTENDED PHENYTOIN SODIUM?
Drug patent expirations by year for EXTENDED PHENYTOIN SODIUM
Drug Prices for EXTENDED PHENYTOIN SODIUM

See drug prices for EXTENDED PHENYTOIN SODIUM

Recent Clinical Trials for EXTENDED PHENYTOIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shaheed Zulfiqar Ali Bhutto Medical UniversityN/A
Hospital Israelita Albert EinsteinPhase 4
Industria FarmacĂȘutica Health MedsPhase 4

See all EXTENDED PHENYTOIN SODIUM clinical trials

US Patents and Regulatory Information for EXTENDED PHENYTOIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Ny EXTENDED PHENYTOIN SODIUM phenytoin sodium CAPSULE;ORAL 040765-001 Nov 12, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds EXTENDED PHENYTOIN SODIUM phenytoin sodium CAPSULE;ORAL 040731-002 Jun 30, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lupin Ltd EXTENDED PHENYTOIN SODIUM phenytoin sodium CAPSULE;ORAL 211633-001 Sep 30, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wockhardt Usa EXTENDED PHENYTOIN SODIUM phenytoin sodium CAPSULE;ORAL 040732-001 Jan 30, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds (in) EXTENDED PHENYTOIN SODIUM phenytoin sodium CAPSULE;ORAL 040621-001 Dec 11, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms EXTENDED PHENYTOIN SODIUM phenytoin sodium CAPSULE;ORAL 040435-001 Jun 20, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.